BIOTRICITY INC.
OTC · CIK 0001630113 · Fiscal year end 0331
Latest reported period: Latest published period
Revenue
$16.0M
Cost Of Revenue
$3.0M
Gross Profit
$12.9M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $16.0M | - | - |
| Cost Of Revenue | $3.0M | - | - |
| Gross Profit | $12.9M | - | - |
| Operating Income | $1.7M | - | - |
| Net Income | $-2.4M | - | - |
| Eps Basic | -0.115 | - | - |
| Eps Diluted | -0.115 | - | - |
| Cash And Equivalents | $149,789 | - | - |
| Total Assets | $6.4M | - | - |
| Total Liabilities | $39.4M | - | - |
| Shareholders Equity | $-34.7M | - | - |
| Operating Cash Flow | $-718,955 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-K | BIOTRICITY INC. | 2026-07-14 | 0001493152-26-033207 |
| 10-Q | BIOTRICITY INC. | 2026-02-11 | 0001493152-26-006211 |
| 10-Q | BIOTRICITY INC. | 2025-11-14 | 0001493152-25-023361 |
| 10-Q | BIOTRICITY INC. | 2025-08-14 | 0001641172-25-023709 |